283 related articles for article (PubMed ID: 15792678)
1. Incidence of heparin-PF4 complex antibody formation and heparin-induced thrombocytopenia in acute coronary syndrome.
Matsuo T; Tomaru T; Kario K; Hirokawa T;
Thromb Res; 2005; 115(6):475-81. PubMed ID: 15792678
[TBL] [Abstract][Full Text] [Related]
2. Preexisting antibodies to platelet factor 4-heparin complexes in patients with acute coronary syndrome who have no history of heparin exposure.
Matsuo T; Suzuki S; Matsuo M; Kobayasi H
Pathophysiol Haemost Thromb; 2005; 34(1):18-22. PubMed ID: 16293981
[TBL] [Abstract][Full Text] [Related]
3. Anti-platelet factor 4/heparin antibodies: an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes.
Williams RT; Damaraju LV; Mascelli MA; Barnathan ES; Califf RM; Simoons ML; Deliargyris EN; Sane DC
Circulation; 2003 May; 107(18):2307-12. PubMed ID: 12707235
[TBL] [Abstract][Full Text] [Related]
4. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
Foo SY; Everett BM; Yeh RW; Criss D; Laposata M; Van Cott EM; Jang IK
Am Heart J; 2006 Aug; 152(2):290.e1-7. PubMed ID: 16875910
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
Everett BM; Yeh R; Foo SY; Criss D; Van Cott EM; Laposata M; Avery EG; Hoffman WD; Walker J; Torchiana D; Jang IK
Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993
[TBL] [Abstract][Full Text] [Related]
7. The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population.
Mullen MP; Wessel DL; Thomas KC; Gauvreau K; Neufeld EJ; McGowan FX; Dinardo JA
Anesth Analg; 2008 Aug; 107(2):371-8. PubMed ID: 18633010
[TBL] [Abstract][Full Text] [Related]
8. Role of platelet factor 4-heparin complex antibody (HIT antibody) in the pathogenesis of thrombotic episodes in patients on hemodialysis.
Nakamoto H; Shimada Y; Kanno T; Wanaka K; Matsuo T; Suzuki H
Hemodial Int; 2005 Oct; 9 Suppl 1():S2-7. PubMed ID: 16223438
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic events in patients with antiplatelet factor 4/heparin antibodies.
Mattioli AV; Bonetti L; Carletti U; Ambrosio G; Mattioli G
Heart; 2009 Aug; 95(16):1350-4. PubMed ID: 19482851
[TBL] [Abstract][Full Text] [Related]
10. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A
Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
[TBL] [Abstract][Full Text] [Related]
11. P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment.
Papalambros E; Sigala F; Travlou A; Bastounis E; Mirilas P
J Am Coll Surg; 2004 Jul; 199(1):69-77. PubMed ID: 15217633
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytopenia in patients with an acute coronary syndrome (from the Global Registry of Acute Coronary Events [GRACE]).
Gore JM; Spencer FA; Gurfinkel EP; López-Sendón J; Steg PG; Granger CB; FitzGerald G; Agnelli G;
Am J Cardiol; 2009 Jan; 103(2):175-80. PubMed ID: 19121432
[TBL] [Abstract][Full Text] [Related]
13. Impact of heparin-induced thrombocytopenia on postoperative outcomes after cardiac surgery.
Kerendi F; Thourani VH; Puskas JD; Kilgo PD; Osgood M; Guyton RA; Lattouf OM
Ann Thorac Surg; 2007 Nov; 84(5):1548-53; discussion 1554-5. PubMed ID: 17954061
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
[TBL] [Abstract][Full Text] [Related]
15. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
[TBL] [Abstract][Full Text] [Related]
17. Titre of anti-heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems.
Chilver-Stainer L; Lämmle B; Alberio L
Thromb Haemost; 2004 Feb; 91(2):276-82. PubMed ID: 14961154
[TBL] [Abstract][Full Text] [Related]
18. Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report.
Brener SJ; Milford-Beland S; Roe MT; Bhatt DL; Weintraub WS; Brindis RG;
Am Heart J; 2008 Jan; 155(1):140-6. PubMed ID: 18082505
[TBL] [Abstract][Full Text] [Related]
19. Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice.
Wang TY; Ou FS; Roe MT; Harrington RA; Ohman EM; Gibler WB; Peterson ED
Circulation; 2009 May; 119(18):2454-62. PubMed ID: 19398666
[TBL] [Abstract][Full Text] [Related]
20. Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: prevalence of thrombosis in a 1 year follow-up.
Mattioli AV; Bonetti L; Sternieri S; Mattioli G
Ital Heart J; 2000 Jan; 1(1):39-42. PubMed ID: 10868921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
